FDA OKs HLA typing systems from Life Technologies

02/12/2013 | GenomeWeb Daily News (free registration)

The FDA has given Life Technologies 510(k) clearance to market its SeCore HLA typing test kits and 3500 Dx Genetic Analyzers. The company said the devices are the first sequencing-based tools to be cleared in the U.S. for HLA typing.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Wayzata, MN
Meridian Health Plan
Detroit, MI